1. Home
  2. KIDS vs IRWD Comparison

KIDS vs IRWD Comparison

Compare KIDS & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OrthoPediatrics Corp.

KIDS

OrthoPediatrics Corp.

N/A

Current Price

$31.63

Market Cap

588.8M

Sector

Health Care

ML Signal

N/A

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

N/A

Current Price

$4.38

Market Cap

578.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KIDS
IRWD
Founded
2007
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
588.8M
578.3M
IPO Year
2016
2009

Fundamental Metrics

Financial Performance
Metric
KIDS
IRWD
Price
$31.63
$4.38
Analyst Decision
Buy
Buy
Analyst Count
7
4
Target Price
★ $30.75
$6.10
AVG Volume (30 Days)
413.0K
★ 1.6M
Earning Date
10-27-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.91
Revenue
$98,049,000.00
★ $298,276,000.00
Revenue This Year
$14.33
$59.19
Revenue Next Year
$12.13
$4.80
P/E Ratio
★ N/A
$7.00
Revenue Growth
★ 37.95
8.88
52 Week Low
$14.42
$2.31
52 Week High
$34.53
$5.78

Technical Indicators

Market Signals
Indicator
KIDS
IRWD
Relative Strength Index (RSI) 70.30 69.47
Support Level $15.56 $3.99
Resistance Level N/A $4.53
Average True Range (ATR) 1.72 0.20
MACD 0.70 0.10
Stochastic Oscillator 77.32 95.75

Price Performance

Historical Comparison
KIDS
IRWD

About KIDS OrthoPediatrics Corp.

OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: